Phynova Group Ltd.

Phynova Group Ltd. is a British life science company that develops and commercialises natural health ingredients derived from plants. According to its own account, the company began at the Oxford Science Park in 2002 with a vision of discovering drug candidates by applying new technology to medicinal plants, and it later broadened its focus to include natural functional ingredients for the consumer healthcare and food industries. It is headquartered in Banbury, Oxfordshire, in the United Kingdom, and operates as a private company. Phynova describes itself as specialising in identifying and researching active ingredients from plants with a long history of use in traditional medicine, then building the scientific, intellectual property and regulatory framework needed to commercialise those ingredients globally. Its stated focus is metabolic health, and its development engine is intended to convert traditionally used plants into novel products validated by contemporary science and protected by IP. The company says it has over 20 years of expertise in developing and commercialising science-backed ingredients. Phynova's flagship offering is Reducose®, a patented plant-powered functional ingredient for healthy blood glucose. The company states that Reducose® works by partially blocking the digestion of carbohydrates, thereby reducing post-meal blood glucose and insulin spikes, and that its efficacy is supported by more than ten published clinical trials with further studies ongoing. It is positioned as convenient because of a small 250 mg serving size, and as easy to formulate because it is fully water-soluble, heat stable and easily masked, allowing incorporation into supplements, foods and beverages. Phynova says Reducose® is available in more than 30 countries, is fully traceable from farm to shelf, is non-GMO verified, and that more than 250 million servings have been sold. Beyond Reducose®, Phynova states that it maintains a portfolio of functional ingredients, cosmeceuticals, pharmaceuticals and OTC drugs developed under the THMP (Traditional Herbal Medicinal Products) directive framework. The company presents itself as a business-to-business ingredient developer and supplier rather than a consumer-facing brand, working with partners in the supplement, food and beverage sectors. Its website provides scientific references, quality documentation and a library of materials for customers and partners, and it maintains a presence in India, as indicated by a 2025 news item about capsules. As a privately held British life science business, Phynova occupies the intersection of botanical research, functional food ingredients and metabolic health. Its identity rests on translating traditional plant knowledge into clinically evidenced, patent-protected ingredients for global consumer health markets.

Phynova Group Ltd. traces its origins to 2002, when it began at the Oxford Science Park in the United Kingdom. According to the company's own history, its founding vision was to discover drug candidates by applying new cutting-edge technology to medicinal plants. This placed the venture at the intersection of ethnobotany, natural product chemistry and modern drug discovery. In its early years, Phynova pursued drug discovery from plant sources. Over time, the company broadened its focus beyond pharmaceuticals to include the development of natural functional ingredients for the consumer healthcare and food industries. This strategic shift reflected the growing global market for functional foods and supplements, and it ultimately produced the company's best-known asset: Reducose®, a postprandial blood glucose management ingredient. By the 2020s, Phynova had repositioned itself as a British life science company specialising in developing and commercialising unique, science-proven health ingredients powered by plants. Its stated approach is to identify active ingredients from plants with a rich history and track record of use in traditional medicine, then develop the scientific, intellectual property and regulatory framework around those ingredients so they can be commercialised globally for a variety of health benefits and unmet needs. The company says it has accumulated more than 20 years of expertise in this field. Reducose® became the centrepiece of the business. Phynova reports that the ingredient's efficacy is supported by more than ten published clinical trials, with five ongoing clinicals, and that it works immediately by partially blocking the digestion of carbohydrates, reducing post-meal blood glucose and insulin spikes. The company highlights a small 250 mg serving size, water solubility, heat stability and easy masking as formulation advantages, and notes that consumers can observe its effects in real time using continuous glucose monitors. Phynova states that Reducose® is available in more than 30 countries, is fully traceable from farm to shelf, is non-GMO verified, and that more than 250 million servings have been sold. Alongside Reducose®, Phynova describes a portfolio of functional ingredients, cosmeceuticals, pharmaceuticals and OTC drugs developed under the THMP directive. The company is headquartered in Banbury, Oxfordshire, and remains a private British enterprise. Its website continues to publish scientific references, quality ecosystem documentation and news, including a 2025 item relating to capsules in India, indicating ongoing international commercial activity.

• 2025

  News item 'CAPSULES - INCREDIO - INDIA' published on the company website.

• 2002

  Phynova begins at the Oxford Science Park with a vision of discovering drug candidates from medicinal plants.

• Company broadens its focus to include natural functional ingredients for the consumer healthcare and food industry, leading to Reducose®.

• Reducose® becomes the flagship patented plant-powered functional ingredient for healthy blood glucose.

Business-to-business life science ingredient developer commercialising science-proven, plant-derived health ingredients, with a focus on metabolic health.

• Reducose®

  Patented plant-powered functional ingredient for healthy blood glucose; partially blocks carbohydrate digestion, reducing post-meal blood glucose and insulin spikes; 250 mg serving; water-soluble, heat stable, easily masked; available in 30+ countries; non-GMO verified.

• Functional ingredients portfolio

  Range of natural health ingredients derived from active compounds in plants and foods.

• Cosmeceuticals, pharmaceuticals and OTC drugs

  Products developed under the THMP directive framework.

1. 1Phynova | Harnessing the Therapeutic Power of Plantsphynova.com
2. 2History | Phynovaphynova.com
3. 3About us | Phynovaphynova.com
4. 4Products | Phynovaphynova.com
5. 5Phynova Group Ltd. (United Kingdom) - Wikidatawikidata.org